1800-272-662
Shopping Cart 0
countryflagAU
Login

The Hydration Pharmaceuticals Company Ltd

Consumer Defensive AU HPC

0.005AUD
-(-%)

Last update at 2026-03-11T23:00:00Z

Day Range

0.0050.005
LowHigh

52 Week Range

0.0040.02
LowHigh

Fundamentals

  • Previous Close 0.005
  • Market Cap2.15M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-10.69844M
  • Revenue TTM2.47M
  • Revenue Per Share TTM0.006
  • Gross Profit TTM 1.36M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.84722M -5.67427M -8.10238M -10.60717M -8.96650M
Minority interest - - - - -
Net income -2.96066M 2.67M -8.10238M -10.60717M -8.96650M
Selling general administrative - 3.05M 6.29M 6.17M 4.49M
Selling and marketing expenses - 2.77M 6.85M 9.23M 4.83M
Gross profit -0.02742M 1.62M 5.39M 4.70M 2.58M
Reconciled depreciation - - - - 0.00460M
Ebit - -8.10750M -7.74188M -10.70178M -5.32660M
Ebitda -3.25592M -3.91061M -7.45948M -10.51596M -5.32326M
Depreciation and amortization - 4.20M 0.28M - 0.00334M
Non operating income net other - - - - -
Operating income -3.25592M -4.19689M -6.86513M -10.51596M -5.32660M
Other operating expenses 5.81M 7.40M 17.78M 19.80M 12.66M
Interest expense 0.00007M 1.76M 0.64M 0.09M 3.64M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - - - 0.00001M 0.00013M
Net interest income - -1.76367M -0.64290M -0.09120M -3.95351M
Extraordinary items - 8.34M -0.87404M - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.00000M -0.36050M - 5.05M
Total revenue 2.56M 3.20M 10.04M 9.10M 5.92M
Total operating expenses 3.23M 5.82M 8.77M 15.40M 9.32M
Cost of revenue 2.59M 1.58M 4.65M 4.40M 3.34M
Total other income expense net 0.41M -1.47739M -0.36050M 0.19M 1.41M
Discontinued operations - - - - -
Net income from continuing ops - -5.67427M -8.10238M -10.60717M -12.34864M
Net income applicable to common shares - 2.67M -8.10238M -10.60717M -8.95166M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.19M 5.00M 6.69M 10.39M 15.31M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.12M 0.34M 0.71M 1.01M 1.80M
Total liab 0.77M 2.25M 7.05M 6.41M 2.08M
Total stockholder equity 1.42M 2.74M -0.35825M 3.98M 13.23M
Deferred long term liab - - - - -
Other current liab 0.63M 1.96M 2.07M 2.22M 1.49M
Common stock 40.51M 39.67M 39.33M 36.61M 36.45M
Capital stock - - - 36.61M 50.22M
Retained earnings -43.30072M -40.41063M -43.07816M -34.97578M -24.38346M
Other liab - - - 0.02M 0.02M
Good will - - - - -
Other assets - - - 0.00000M -
Cash 1.12M 3.22M 1.84M 4.69M 10.67M
Cash and equivalents - - - - -
Total current liabilities 0.77M 2.23M 3.13M 2.68M 2.06M
Current deferred revenue - - - - -
Net debt -1.11933M -3.21651M 2.05M -0.97641M -10.67253M
Short term debt - - - 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total - - 3.89M 3.71M -
Other stockholder equity - - 0.00000M 2.34M -0.04825M
Property plant equipment - - - - 0.00000M
Total current assets 2.19M 5.00M 6.69M 10.39M 15.31M
Long term investments - - - - -
Net tangible assets - - - 3.98M 13.23M
Short term investments - - - - -
Net receivables 0.08M 0.34M 1.74M 1.31M 1.04M
Long term debt - - - 3.71M -
Inventory 0.87M 1.10M 2.39M 3.39M 1.79M
Accounts payable 0.15M 0.28M 1.06M 0.45M 0.57M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 4.21M 3.48M 3.39M 2.34M 1.21M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - 3.71M 0.00000M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 9.44M - - -
Change to liabilities - - - 0.00000M -0.13263M
Total cashflows from investing activities - 9.44M - - 0.00000M
Net borrowings - -6.50415M - 4.08M 4.08M
Total cash from financing activities 0.83M -3.62819M 2.72M 4.08M 17.03M
Change to operating activities - - - 0.67M -1.40286M
Net income -2.84722M 2.67M -8.10238M -10.60717M -12.34864M
Change in cash -2.34732M 1.38M -2.84792M -5.98434M 9.03M
Begin period cash flow 3.47M 1.84M 4.69M 10.67M 1.64M
End period cash flow 1.12M 3.22M 1.84M 4.69M 10.67M
Total cash from operating activities -3.78118M -3.01955M -5.72971M -9.75184M -8.07805M
Issuance of capital stock - - 2.96M - 16.60M
Depreciation - - - - 0.00334M
Other cashflows from investing activities - 9.44M - - 0.00000M
Dividends paid - - - - -
Change to inventory 0.23M 0.86M 0.85M -1.72145M -0.20924M
Change to account receivables 0.27M 1.40M -0.43771M - -0.23795M
Sale purchase of stock - -0.02397M -0.24136M - 12.03M
Other cashflows from financing activities - -0.02397M -0.25317M - 4.99M
Change to netincome - - - 0.86M 2.53M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.89005M 2.49M 0.41M - -8.07805M
Stock based compensation - - 1.03M - -
Other non cash items -0.04391M -8.18162M 0.93M - -
Free cash flow -3.78118M -3.01955M -5.72971M -9.75184M -11.14351M

Peer Comparison

Sector: Consumer Defensive Industry: Food Distribution

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HPC
The Hydration Pharmaceuticals Company Ltd		 - -% 0.005 - - 0.87 1.08 1.66 -0.9336
MTS
Metcash Ltd		 0.01 0.34% 2.97 11.42 11.15 0.19 1.96 0.29 7.03

Reports Covered

Stock Research & News

View All

Profile

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. It sells its products under the Hydralyte brand through retail stores and online. The company was founded in 2001 and is based in Melbourne, Australia.

The Hydration Pharmaceuticals Company Ltd

6 Palmer Parade, Cremorne, Melbourne, VIC, Australia, 3121

Key Executives

Name Title Year Born
Mr. Oliver Baker Chief Exec. Officer NA
Mr. Chris Kavanaugh Chief Financial Officer NA
Ms. Carlie Hodges Company Sec. NA
Mr. Oliver Baker Chief Executive Officer NA
Ms. Victoria Nadalin Company Secretary NA
Mr. Oliver Baker Chief Executive Officer NA
Ms. Victoria Nadalin Company Secretary NA
Ms. Victoria Alexis Nadalin Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.